PD-L1 diagnostics in the neoadjuvant setting: implications of intratumoral heterogeneity of PD-L1 expression in triple negative breast cancer for assessment in small biopsies
Elisabeth Specht Stovgaard, M. Bokharaey, Kamille List-jensen, Anne Roslind, Iben Kümler, Estrid Høgdall, Dorte Nielsen, Eva Balslev
Topics & Concepts
Breast cancerTriple-negative breast cancerMedicineOncologyNeoadjuvant therapyInternal medicineCancerPathologyCancer researchCancer Immunotherapy and BiomarkersBreast Cancer Treatment StudiesImmunotherapy and Immune Responses